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ABSTRACT
We reported here a rare case of a 62 year old male patient with obstructive jaundice due to bile duct
tumor. The main clinical features were yellowish eye and skin, followed by pruritus and clay-colored stool.
Ultrasonography showed common bile duct dilatation and without evidence of stones. Computed
Tomography Scan of upper abdomen showed a mass which were thought of head of pancreas origin.
Endoscopic Retrograde Cholangio Pancreatograph revealed tight narrowing of the distal bile duct to a
malignant tumor. A stent was inserted to allow biliary drainage. A surgical plan for billio digestive
anastomosis was rejected by the patient and family.
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INTRODUCTION
Biliary tract tumor is the second most common
primary hepatobiliary cancer, after hepatocellular
cancer.1 Although the numbers vary among countries
and regions, about two thirds of all cases are perihilar
tumors, about one fourth are distal extra hepatic tumors,
and the remainder are intrahepatic.2,3 They are more
common in males being about 60 years old and
associated with liver flukes, primary sclerosing
cholangitis, chronic ulcerative colitis and congenital
anomalies (most frequently Carole’s syndrome).3 In the
Far East (China, Hong Kong, Korea, Japan), where
Clonorchis sinensis is prevalent, cholangiocarcinoma
accounts for 20% of primary liver tumors. Opisthorcis
viverrini infestation is important in Thailand, Laos and
western Malaysia.1-3 These parasites induce DNA
changes and mutations through the production of
carcinogens and free radicals, and the stimulation of
cellular proliferation of intra-hepatic bile duct epithelium.3
Grossly, the bile duct tumor can be divided into three
types: polypoid or nodular masses, sclerosing and
diffusely infiltrating.3,4 Symptoms of bile duct tumor are
nonspecific gastrointestinal complaints that include
nausea, vomiting, anorexia and weight loss.1,5 Painless
jaundice is the most prominent sign and is usually
followed by pruritus – a point of distinction from primary
biliary cirrhosis where itching usually comes first.2,3
Cholestasis and cholecytis due to obstruction of bile flow
typically result in moderate-to-marked increases in
serum levels of alkaline phosphatase, bilirubin,
g-glutamiltransferase, and bile acids, whereas
aminotransferase levels are only mildly elevated or
normal.5 Tumor markers, however are not specific and
may also be present in nonmalignant conditions. Cancer
antigen (CA) 19-9 in combination with carcinoembryonic
antigen (CEA) has an accuracy of 86%.6 Ultrasono-
graphy may show ductal dilatation throughout the
obstructed liver segments, an abrupt change in ductal
diameter may indicate the exact location of the tumor.3,6
Computed tomographic (CT) scanning may show intra-
hepatic mass lesions and dilated intrahepatic ducts, which
can be unilobate or bilobate suggesting of perihilar
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tumor.1,3 Magnetic resonance imaging (MRI) permits
excellent visualization of hepatic parenchyma
abnormalities, as well as the visu-alization of the biliary
tree and vascular structures.5 MRI may replace CT and
angiography for the preoperative assessment of biliary
tract tumors.5,6 In some centers, endoscopic retrograde
cholangio-pancreatography (ERCP) has proved to be the
most useful modality in diagnosis of malignancy in the
distal biliary tree.2 It allows collection of bile juice or
brush cytology for cytologic examination, but requires
cytological expertise for interpretation.2,4 Cholangio-
graphy has its own role in preoperative assessment.
Information obtained from cholangiography and hepatic
arteriography may determinate the extention of the
tumor and its resectability.2,3
If the clinical state of the patient does not rule out
surgery the resectability and extent of tumor is assessed.3
Metastases, usually late, should be sought.3,4 There are
two objectives in treatment, which are to cure the
patient of tumor and to relieve the bile duct obstruction
to prevent hepatic failure.1 Resection local or extensive
is required. If unrespectable, palliative decompression
of the bile ducts should be performed. Other modalities
such as radiotherapy used in combination with total
resection or in combination with chemotherapy
(fluorouracil) and supplemental transcatheter
brachytherapy, survival appears to be prolonged.1-7
Chemotherapy preoperative or postoperative does not
significantly improve survival or the quality of life in
patients with bile duct tumors. In overall the prognosis is
poor; it depends on histopathology of the tumor and the
stage of the disease.2,3,5
CASE REPORT
Male, 62 years, was admitted to Dr. Cipto
Mangunkusumo General National Hospital with chief
complaint of     yellowish colored skin and eyes since 10
days prior to admission. Fourteen days before admission
he felt     feverish, continuously, but only last for about 4
days, he didn’t feel nausea but lost his appetite, had
darked urine and clay colored stool, and developed
pruritus afterwards. He never had hepatitis before, had
no history of blood transfusion, and denied consumption
of alcohol nor traditional herbal medicine. He had not
experienced  symptoms like this before, and had no
relatives suffered of malignancy. The patient and family
were of middle economic status and education. From
physical examination, he was moderately ill, his whole
body looked icteric, vital on signs were within normal
limits, had icteric sclera, hepatomegaly, blunt edge but
smooth liver surface and no tenderness of liver. The
spleens were not palpable and no lymph nodes were
palpable.
Laboratory examination findings were: hemoglobin
13.2 g/dL, hematocryte 39%, white blood cell count
6,800/mm3, platelet count 472,000/mm3, urea level 30 mg/
dL, creatinine level 0.9 mg/dL, blood glucose level 126
mg/dL, AST (aspartate aminotransferase) 49 IU/mL,
ALT (alanine aminotransferase) 64 IU/mL, albumin 4.29
mg/dL, globulin 2.17 mg/dL, total bilirubin 13.8 mg/dL,
direct bilirubin 11.2 mg/dL, indirect bilirubin 2.6 mg/dL,
g-glutamil transferase 622 g/dL, CEA 27.2 ng/mL,
Ca 19-9 2349 ng/mL, HbsAg negative, anti HCV
negative and IgM anti HAV negative.
Ultrasonography showed obstructive jaundice were
thought caused head of pancreatic mass. A CT scan of
upper abdomen showed intra and extra hepatic bile duct
dilatation with a mass suspected (arrive for head of
pancreas mass). The findings from ERCP showed
papilla vateri and cannulation of the pancreatic duct were
normal but cannulation of the bile duct was difficult.
A papilotomy precut were performed and allowed
passage of black colored bile juice, and with guidance of
guide wire a stent were inserted. The radiology with
Figure 1. ERCP showing proximal dilatation of common bile duct with
distal narrowing and stenting were done. Arrow shows filling de-
fect which were presumptive the location of the bile duct tumor.
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contrast results showed normal appearance of
pancreatic duct, but irregular shaped bile duct with a
filling defect at one third proximal bile duct and dilated
bile duct which concluded a proximal bile duct tumor.
After the ERCP amylase, lipase and bilirubin were
re-measured, and amylase 193 u/L, lipase 107 u/L and
total bilirubin 6.8 mg/dL, direct bilirubin 4.8 mg/dL and
indirect bilirubin 2.0 mg/dL. The patient felt better, got
his appetite back and didn’t felt itchy anymore. Surgery
was planned, but the patient and family refused to un-
dergo surgery.
DISCUSSION
 Obstructive jaundice due to bile a duct tumor is rare,2
but currently it appears to be found more frequent. It is
more common in male, being about 60 years old which
resembles this patient.1-3 Symptoms of bile duct tumors
are not specific, they consist of icterus, gastrointestinal
symptoms (nausea, vomiting, and loss of appetite), darked
urine, clay colored stool and pruritus.1-3 Physical
examinations shows icterus and liver enlargement,
laboratory examinations shows serologic findings of
increased bilirubin especially direct bilirubin,  increased
alkaline phosphates, increased g-glutamil transferase,
increased CEA, increased Ca 19-9 which conclude to
obstructive jaundice but is not specific for bile duct
tumor.1-3,5 Because bile obstruction due to stone and
pancreatic mass is more prevalent, symptoms and physical
examination alone can not come to any conclusion.
Imaging procedure like   ultrasonography, computed
tomographic scan, and or magnetic resonance
cholangio-pancreatography has to be performed.5
In this case the ultrasonography and CT scan showed
intra hepatic duct dilatation, and no signs of stones, but
from the CT scan a mass were visualized which
presumptive head of pancreas were mass. But
endoscopic retrograde cholangio-pancreatography made
it all clear, which the mass were not from the head of
pancreas, but from the bile duct. When the ERCP were
performed, because cannulation of the bile duct was
difficult, a precut sphincterotomy were used to dissect
the papilla to expose the bile duct. Traumatizing the
papilla by repeated attempts at cannulation leads to edema
and sphincter spasm and can temporarily occlude the
outflow of pancreatic juice thereby increasing the intra
pancreatic pressure and the risk of pancreatitis.7 While,
precutting if not performed by an experienced
endoscopist can have disastrous effects, such as severe
acute pancreatitis, large perforation of the duodenal wall
and severe bleeding. In this patient, pancreatitis as side
effect from ERCP or papilotomy precut did not occur.
That could be probably because of his age (62 years),
when the pancreatic exocrine function is already declined
because of aging.7
 Radiologic pictures which were taken with contrast
during the ERCP showed irregularity of the bile duct
and dilatation, and the pancreatic duct were normal. The
mass were predicted in one third of the proximal site
from the radiologic picture. But unfortunately, cytologic
specimen from bile juice or cytologic brush was not
obtained, because of the risk which may occur. But
obstruction were relieved by inserting a stent, which were
Figure 2. Regular shape and normal diameter of pancreatic duct on
ERCP.
Figure 3. Computed Tomographic Scan of upper abdomen shows
a mass in the head of the pancreas.
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quiet effective, the bilirubin decreased from 13.8 mg/dL
to 6.8 mg/dl, so biliary cirrhosis could be prevented. But
as we know plastic stent often become obstructed by
the growth of a biofilm (a layer of bacteria and mucin)
on the surface, it is necessary to inform the patient about
this situation and he has to check his stent for 2-3 months
after insertion and if it is necessary the stent has to be
replaced with a new one.6
Etiology of this tumor could not be primary
sclerosing cholangitis, chronic ulcerative colitis or
congenital anomalies, because he does not have history
of abdominal pain or enteritis. In fact he never
experienced these symptoms before. But liver flukes
could still be of cause.
Treatment of bile duct cancer depends on the stage
of the disease.1-3,5 Resection of the tumor followed by
intra operative radiotherapy appears to prolong the
survival rate of the patient. Distant metastases,
extensive regional lymphadenopathy and regional
vascular encasement or invasion preclude resection, so
palliative treatment should be done.1-3,5 As we see in
this patient there were no evidence of distant metastases,
extensive regional lymph node enlargement or regional
vascular invasion, so at the time the diagnose has been
made, the patient still operable which unfortunately
after we informed the patient and family about his
situation he chose not to undergo surgery.
Because this patient was still stage 2 or 3 and the
location of the tumor was one third of proximal bile duct,
resection followed with hepaticojejunostomy for the
billiary-enteric continuity could have been the treatment
of choice. Afterwards radiotherapy or chemotherapy or
both as combination could prolong the survival rate.4 But
since, this patient refuse resection and the stent can re-
occlude with all of its complication, the prognosis of this
disease in this patient is poor.
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